Skip to main content
. 2023 Jun 2;18(6):e0286394. doi: 10.1371/journal.pone.0286394

Table 1. Patient demographic, laboratory, and clinical characteristics.

Total Cases Activated T-cell hepatitis Indeterminate PALF P value
n = 8 n = 4 n = 4
At Study Enrollment
Age, years 6.5 (3.0–12.3) 4.0 (3.0–7.0) 10.0 (6.3–12.8) 0.63
Gender, male 4 (50) 2 (50) 2 (50) >0.99
Symptoms prior to admission, weeks 2.0 (0.9–3.0) 3.0 (2.8–3.0) 0.8 (0.5–1.3) 0.06
Hepatic encephalopathy level 0–1 5 (63) 3 (75) 2 (50) >0.99
Alanine aminotransferase (IU/L) 2167 (1279–5317) 1576 (1276–1965) 6545 (3303–9800) 0.20
Total bilirubin (mg/dL) 14.6 (3.3–18.5) 18.6 (17.5–19.8) 2.6 (1.1–6.6) 0.03
International normalized ratio 2.1 (2.1–2.3) 2.1 (2.0–2.1) 2.3 (2.1–3.0) 0.48
Total white blood cell count (1000/mm3) 4.0 (3.2–8.0) 3.0 (2.2–4.9) 6.1 (4.2–9.6) 0.20
Hemoglobin (g/dL) 11.2 (10.2–12.7) 10.6 (10.2–11.6) 11.9 (10.8–12.8) 0.68
Platelet count (1000/mm3) 183 (150–242) 183 (150–218) 199 (131–256) >0.99
Worst values during admission
Hepatic encephalopathy level 2–4 4 (50) 2 (50) 2 (50) >0.99
Highest alanine aminotransferase (IU/L) 2381 (1513–7249) 1876 (1513–2249) 7833 (5283–9988) 0.34
Highest total bilirubin (mg/dL) 20.4 (4.1–22.1) 21.6 (20.4–22.6) 3.2 (1.1–9.2) 0.11
Highest international normalized ratio 2.3 (2.2–2.5) 2.3 (2.2–2.4) 2.3 (2.2–3.0) 0.86
Lowest total white blood cell count (1000/mm3) 1.7 (1.3–3.7) 1.7 (1.3–5.5) 1.9 (1.3–3.7) >0.99
Lowest hemoglobin (g/dL) 10.3 (7.5–11.4) 10.3 (9.4–11.0) 9.2 (7.3–11.6) 0.89
Lowest platelet count (1000/mm3) 95 (48–179) 140 (100–179) 60 (44–115) 0.68
Outcome and follow up
Duration of admission, days 12.0 (7.8–16.3) 9.0 (7.8–11.3) 13.5 (6.3–18.5) 0.48
Admission to normal liver enzymes, days 92.0 (57.5–107.0) 110.0 (92.0–130.0) 52.0 (39.5–72.3) 0.11
Developed aplastic anemia 2 (25) 2 (50) 0 0.43

aData are medians (interquartile range) or n (%).